van Rooijen N, van Nieuwmegen R, Kors N
Cell Tissue Res. 1985;239(3):657-60. doi: 10.1007/BF00219245.
Rabbits received an injection of liposome-associated human serum albumin (HSA) and six weeks later a booster injection of HSA free in solution. Anti-HSA antibody-forming cells were demonstrated in the popliteal lymph nodes by use of a HSA-horseradish peroxidase (HRP) conjugate for their detection. After a single subcutaneous injection into the footpads, specific antibody-forming cells were found, but after a single intravenous injection no anti-HSA-forming cells were observed in the lymph nodes. During the secondary immune response specific anti-HSA antibody-producing cells were found in the lymph nodes of all animals. The localization pattern of anti-HSA antibody-forming cells within the lymph nodes depended on the route of antigen administration used for the primary and booster injection. Anti-HSA-forming cells were mainly found in the cords of the medulla and in the outer cortex. During the secondary immune response, however, they were also detected in the follicles but only when at least one of the two antigen injections was given subcutaneously.
给兔子注射脂质体结合的人血清白蛋白(HSA),六周后再注射一次溶液中游离的HSA作为加强注射。通过使用HSA-辣根过氧化物酶(HRP)偶联物来检测,在腘淋巴结中证实了抗HSA抗体形成细胞。在单次皮下注射到脚垫后,发现了特异性抗体形成细胞,但在单次静脉注射后,在淋巴结中未观察到抗HSA形成细胞。在二次免疫应答期间,在所有动物的淋巴结中都发现了特异性抗HSA抗体产生细胞。淋巴结内抗HSA抗体形成细胞的定位模式取决于初次注射和加强注射所使用的抗原给药途径。抗HSA形成细胞主要存在于髓索和外皮质中。然而,在二次免疫应答期间,仅当两次抗原注射中至少有一次是皮下注射时,才在滤泡中检测到它们。